A phase II trial of three sequential doublets for the treatment of advanced mullerian malignancies

Author： Matulonis U.   Campos S.   Duska L.   Fuller A.   Berkowitz R.   Gore S.   Roche M.   Colella T.   Lee H.   Seiden M.V.   Gynecologic Oncology Research Program at Dana Farber/Partners Cancer Care and the Dana Farber-Harvard Cancer Center  

Publisher： Elsevier

ISSN： 0090-8258

Source： Gynecologic Oncology, Vol.91, Iss.2, 2003-11, pp. : 293-298

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A phase I pharmacodynamic trial of sequential sunitinib with bevacizumab in patients with renal cell carcinoma and other advanced solid malignancies

By Bruce Justine   Kolesar Jill   Hammers Hans   Stein Mark   Carmichael Lakeesha   Eickhoff Jens   Johnston Susan   Binger Kimberly   Heideman Jennifer   Perlman Scott   Jeraj Robert   Liu Glenn  

Cancer Chemotherapy and Pharmacology, Vol. 73, Iss. 3, 2014-03 ,pp. : 485-493

Springer Publishing Company

Access to resources Recommend Favorite

A phase I study of the oral platinum agent satraplatin in sequential combination with capecitabine in the treatment of patients with advanced solid malignancies

By Gallerani Elisa   Bauer Jean   Hess Dagmar   Boehm Steffen   Droege Cornelia   Jeckelmann Sandrine   Miani Monica   Herrmann Richard   Marsoni Silvia   Sperka Sabine   Sessa Cristiana  

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1105-1110

Informa Healthcare

Access to resources Recommend Favorite

A phase II trial of cisplatin, ifosfamide, and mesna in patients with advanced or recurrent uterine malignant mixed mullerian tumors with evaluation of potential molecular targets

By Ramondetta L.M.   Burke T.W.   Jhingran A.   Schmandt R.   Bevers M.W.   Wolf J.K.   Levenback C.F.   Broaddus R.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 529-536

Elsevier

Access to resources Recommend Favorite

Phase II trial of anastrozole in women with asymptomatic mullerian cancer

By Carmen M.G.d.   Fuller A.F.   Matulonis U.   Horick N.K.   Goodman A.   Duska L.R.   Penson R.   Campos S.   Roche M.   Seiden M.V.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 596-602

Elsevier

Access to resources Recommend Favorite

A phase II trial of cyclophosphamide, epirubicin and vinorelbine in the treatment of advanced breast cancer

By Esteban E.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 2, 2000-07 ,pp. : 127-133

Springer Publishing Company

Access to resources Recommend Favorite